3Vote!
Xconomy (Free subscription) | 28/10/2009
Europe’s drug regulators were not kind to a couple of Massachusetts biotech firms this week, but other New England life sciences companies had happier news to report. —European drug regulators turned down Lexington, MA-based Antigenics’ bid for approval to market vitespen (Oncophage), a “cancer vaccine” for patients with kidney cancer. Shares of Antigenics (NASDAQ: AGEN)...
3Vote!
Head Nurse (Free subscription) | 27/10/2009
And it was really nice. For a whole day and a half, I had nothing to do but eat good food, yammer at interesting people, and listen to Neko Case and Fountains of Wayne on the car stereo. Meanwhile, the family of a patient I had last week was discussing whether or not to turn off the vent and make Grandma a DNR. Grandma is not going to wake up, sadly; she had one of those intracerebral hemorrhages best...
3Vote!
Medindia Health News (Free subscription) | 22/10/2009
The US FDA has given its nod for Votrient (pazopanib) for treatment of advanced kidney cancer. The drug is manufacture b
3Vote!
The Inquisitr (Free subscription) | 22/10/2009
The U.S. Food and Drug Administration approved a new drug for the treatment of kidney cancer this week. The drug, Votrient, is an oral medication that interferes with the growth of new blood vessels that are needed for solid tumor growth and survival. It is made by London drug maker GlaxoSmithKline. Votrient is intended for people with [...]
3Vote!
Fiercebiotech (Free subscription) | 21/10/2009
Antigenics (AGEN) has a fresh round of sour news to report this morning, announcing that European regulators will soon formally reject its kidney cancer vaccine Oncophage. The UK biotech said that it was told of the decision verbally. And discouraged investors quickly bailed on the company's stock, which plunged 43 percent. Antigenics had held out hopes for Oncophage despite two pivotal trial failures...
3Vote!
iStockAnalyst.com (Free subscription) | 21/10/2009
On 6/1/09, Antigenics (NASDAQ: AGEN) announced results of an interim analysis from the Company’s ongoing global patient survival registry, which showed that patients with kidney cancer at intermediate risk of disease recurrence demonstrated an approximately 46% lower risk of death when treated with Oncophage (vitespen) cancer vaccine compared with observation ( [More...]
3Vote!
Health - The Post Chronicle (Free subscription) | 20/10/2009
The FDA said the newly approved drug, Votrient (pazopanib), interferes with angiogenesis --...
3Vote!
Joseph Kim, MD, MPH (Free subscription) | 20/10/2009
Votrient (pazopanib) has been approved by the FDA for the treatment of advanced kidney cancer. Votrient is made by GlaxoSmithKline (GSK). The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow...
3Vote!
The Earth Times Online Newspaper (Free subscription) | 20/10/2009
PHILADELPHIA, Oct. 19 -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved VOTRIENT(TM) (pazopanib) to treat patients with advanced renal cell carcinoma (RCC), a form of kidney cancer. Approxi...
3Vote!
Entertainment and Showbiz! (Free subscription) | 18/10/2009
Staying active may help extend the lives of people with kidney disease, says a new study. According to the study, appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN), exercise has significant health benefits for individuals with kidney dysfunction. Many patients with chronic kidney disease (CKD) die prematurely, but not from [...] Related posts: Patients...
3Vote!
The Mom's Buzz-Tips for Busy Moms (Free subscription) | 16/10/2009
Belafigura is a company started by a kidney cancer survivor, Minoo Mobin-Ventura, whose drive was to provide the proper coverage and support for breast cancer and other cancer survivors in artistic, stylish and beautiful swimwear designs. Belafigura and TigerLily Foundation,...
3Vote!
SpicyBugz World (Free subscription) | 14/10/2009
Someone who is very dear to me, is suffering right now. She lost the most important person in her life, her dad, to Kidney cancer this morning. She wrote a tribute to him that left me in tears after reading it. I wish she wasn’t hurting so bad right now, and I feel so totally [...]
5Vote!
Stuff To Scrap Blog (Free subscription) | 13/10/2009
Many of us have been touched by cancer, in some form, in one way or another. Personally, I have lost my mother and my grandmother to this terrible disease and watched several friends and acquaintances battle cancer as well. That is why I decided to form a group to work on this very special kit. All proceeds from the sale of this kit and it's coordinating Quick Page Set will be donated to the American...
Explore : American Cancer Society,
Bladder Cancer,
Bone Cancer,
Breast Cancer,
Cancers,
Colon Cancer,
Diseases,
Health-Fitness,
Leukemia,
Liver Cancer,
Lung Cancer,
Lymphoma,
Organisations,
Pancreatic Cancer,
Prostate Cancer,
Stomach Cancer
3Vote!
Fitness Watch (Free subscription) | 08/10/2009
Yes. "Your pants size might help gauge your risk of developing certain cancers, regardless of how much you actually weigh, Dutch researchers report. A large waist and wide hips signal accumulation of so-called "intra-abdominal fat" -- the particularly harmful deep "hidden" fat that surrounds the abdominal organs and is linked to type 2 diabetes, high blood pressure and heart...
3Vote!
annies home (Free subscription) | 08/10/2009
The week of October 25 to November 1 Pediped shoes will be high lighted in the Stars for a Wish online auction where 50 well known entertainers and athletes will autograph pairs of pediped baby shoes. The money raised will go to Make A Wish Foundation. Among the 50 pairs of Pediped shoes that will be autographed you will find signatures from Halle Berry, Andy Garcia, Tim Allen, Marcia Cross, Whoopie...
Videos